Penetrium Bioscience Inc. (KOSDAQ:187660)
12,510
-750 (-5.66%)
At close: Apr 28, 2026
630.30% (1Y)
| Market Cap | 685.09B |
| Revenue (ttm) | 9.74B |
| Net Income (ttm) | -20.10B |
| Shares Out | 54.76M |
| EPS (ttm) | -475.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,578,057 |
| Average Volume | 3,517,166 |
| Open | 13,560 |
| Previous Close | 13,260 |
| Day's Range | 12,430 - 13,600 |
| 52-Week Range | 1,118 - 21,500 |
| Beta | 3.02 |
| RSI | 47.63 |
| Earnings Date | Mar 30, 2026 |